Zhang, Yanli
Xia, Zhang
Cai, Xueli
Su, Xin
Jin, Aoming
Mei, Lerong
Jing, Jing
Wang, Suying
Meng, Xia
Li, Shan
Wang, Mengxing
Wei, Tiemin
Wang, Yongjun
He, Yan
Pan, Yuesong
Funding for this research was provided by:
Key Science & Technologies R&D Program of Lishui City (2019ZDYF18)
Zhejiang provincial program for the Cultivation of High-level Innovative Health talents
Ministry of Science and Technology of the People's Republic of China (2016YFC0901002)
AstraZeneca Investment (China) Co., Ltd.
National Natural Science Foundation of China (82073648)
National Key R&D Program of China (2022YFC3602505)
Article History
Received: 12 August 2023
Accepted: 1 December 2023
First Online: 13 December 2023
Declarations
:
: The study protocol was approved by the Ethics Committees of Beijing Tiantan Hospital (IRB approval number: KY2017-010-01) and Lishui Hospital (IRB approval number: 2016-42). Informed consent was obtained from all participants prior to enrollment.
: The authors declare that they have no competing interests.